We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$17.3B
AUM Growth
-$1.13B
Cap. Flow
-$75.7M
Cap. Flow %
-0.44%
Top 10 Hldgs %
25.36%
Holding
830
New
93
Increased
230
Reduced
369
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.67%
3 Financials 12.95%
4 Communication Services 7.42%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$732M 4.22%
3,143,044
-47,752
-1% -$12.6M
UNH icon
2
UnitedHealth
UNH
$385B
$551M 3.18%
1,090,652
-4,242
-0.4% -$2.23M
JNJ icon
3
Johnson & Johnson
JNJ
$624B
$490M 2.83%
3,002,499
+728,785
+32% +$123M
AAPL icon
4
Apple
AAPL
$4.72T
$472M 2.73%
3,417,518
-807,971
-19% -$127M
WFC icon
5
Wells Fargo
WFC
$261B
$410M 2.37%
10,201,175
-127,051
-1% -$5.46M
USB icon
6
US Bancorp
USB
$98.7B
$384M 2.22%
9,527,792
-59,031
-0.6% -$2.73M
TXN icon
7
Texas Instruments
TXN
$260B
$360M 2.08%
2,324,275
-15,311
-0.7% -$2.57M
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$3.89T
$341M 1.97%
3,568,553
-76,267
-2% -$8.46M
KO icon
9
Coca-Cola
KO
$349B
$330M 1.9%
5,887,674
-60,067
-1% -$3.73M
ELV icon
10
Elevance Health
ELV
$82.3B
$324M 1.87%
714,142
-15,466
-2% -$7.4M
ACN icon
11
Accenture
ACN
$84.9B
$314M 1.81%
1,219,753
-87,797
-7% -$25.4M
TJX icon
12
TJX Companies
TJX
$170B
$298M 1.72%
4,789,128
-43,742
-0.9% -$2.75M
ORCL icon
13
Oracle
ORCL
$346B
$292M 1.69%
4,783,909
+69,994
+1% +$5.12M
LRCX icon
14
Lam Research
LRCX
$400B
$277M 1.6%
7,558,160
+38,080
+0.5% +$1.7M
MRK icon
15
Merck
MRK
$322B
$268M 1.54%
3,106,655
-3,300
-0.1% -$295K
LLY icon
16
Eli Lilly
LLY
$1.06T
$254M 1.47%
786,841
-3,068
-0.4% -$972K
META icon
17
Meta Platforms (Facebook)
META
$1.54T
$245M 1.41%
1,804,077
+189,631
+12% +$30.7M
MDT icon
18
Medtronic
MDT
$105B
$241M 1.39%
2,978,752
-10,812
-0.4% -$972K
V icon
19
Visa
V
$669B
$223M 1.28%
1,252,625
-4,406
-0.4% -$897K
AXP icon
20
American Express
AXP
$233B
$219M 1.26%
1,623,890
+66,040
+4% +$10M
AMZN icon
21
Amazon
AMZN
$2.51T
$210M 1.21%
1,859,286
-7,200
-0.4% -$910K
DGX icon
22
Quest Diagnostics
DGX
$25.1B
$208M 1.2%
1,698,633
-36,962
-2% -$4.87M
CI icon
23
Cigna
CI
$75.7B
$192M 1.11%
693,561
-16,706
-2% -$4.7M
TSM icon
24
TSMC
TSM
$2.16T
$192M 1.11%
2,800,873
+249,830
+10% +$20.6M
AMRC icon
25
Ameresco
AMRC
$1.25B
$187M 1.08%
2,806,072
-303,700
-10% -$18.6M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2022 Portfolio in Review

As of Q3 2022, Grantham, Mayo, Van Otterloo & Co (GMO) held 830 positions worth $17.3B, down 6.1% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2022 filing shows 93 new, 230 increased, 369 reduced and 118 closed positions. Its largest new stake was VMware, Inc: 475,895 shares worth $50.7M. The largest sale was Apple, an estimated $127M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2022 buy was VMware, Inc: 475,895 shares worth $50.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Johnson & Johnson in Q3 2022, an estimated $123M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2022 reduction was Apple, cutting an estimated $127M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Healthcare Realty in Q3 2022, selling an estimated $55.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 25% of its $17.3B portfolio in Q3 2022.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 93 new positions and closed 118 in Q3 2022.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 6.1% quarter-over-quarter to $17.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.